ADVERTISEMENT
Highlights
- President Trump demands urgent drug price cuts from 17 pharma firms following his executive order on Most Favored Nation pricing.
- Trump threatens tariffs up to 250% on drug imports and pressures foreign countries to raise prices to lower U.S. drug costs.
- Experts warn raising drug prices abroad may not lower U.S. costs.
- Trump proposes cutting out middlemen, offering lowest developed-nation prices, and ensuring Medicaid gets MFN pricing.
- But legal experts doubt Trump's authority to force pharma changes.